Finally, conjugated PSMA-docetaxel showed the cytotoxic potential to inhibit tumour growth of PCa close to unmodified docetaxel, an effect accompanied with lower toxicity than docetaxel itself (Machulkin et al. 2022). The gene discussed is FOLH1; the disease is posterior cortical atrophy.